Anti-VEGF [Bevacizumab]
Ab00715-15.0
ApplicationsFlow Cytometry, ImmunoPrecipitation, Western Blot, ELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetVEGFA
Overview
- SupplierAbsolute Antibody
- Product NameAnti-VEGF [Bevacizumab]
- Delivery Days Customer7
- Antibody SpecificityThis antibody binds native and reduced human VEGF (isoform 165).
- Application Supplier NoteThis is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.
- ApplicationsFlow Cytometry, ImmunoPrecipitation, Western Blot, ELISA, Neutralisation/Blocking
- Applications SupplierELISA; IP; WB; Block; FC
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDBevacizumab
- Gene ID7422
- Target nameVEGFA
- Target descriptionvascular endothelial growth factor A
- Target synonymsMVCD1; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VPF
- HostHuman
- IsotypeIgM
- Protein IDP15692
- Protein NameVascular endothelial growth factor A
- Scientific DescriptionThis reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
- ReactivityHuman
- Reactivity SupplierHuman
- Reactivity Supplier NoteRecombinant human VEGF.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203